Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational and medicinal purposes. In many countries, cannabis‐based medicines have been legalized under certain conditions because of their immense prospects in medicinal applications. With a comprehensive insight into the prospects and challenges associated with the pharmacological use and global trade of C. sativa, this mini‐review focuses on the medicinal importance of the plant and its legal status worldwide; the pharmacological compounds and its therapeutic potential along with the underlying public health concerns and future perspective are herein discussed. The existence of major compounds including Δ9‐tetrahydrocannabinol (Δ9‐THC), cannabidiol, cannabinol, and cannabichromene contributes to the medicinal effects of the cannabis plant. These compounds are also involved in the treatment of various types of cancer, epilepsy, and Parkinson's disease displaying several mechanisms of action. Cannabis sativa is a plant with significant pharmacological potential. However, several aspects of the plant need an in‐depth understanding of the drug mechanism and its interaction with other drugs. Only after addressing these health concerns, legalization of cannabis could be utilized to its full potential as a future medicine.

The breakdown of plant lignin modifies the structure of lignocelluloses, thus making carbohydrates accessible for efficient bioconversion. White-rot fungi produce ligninolytic enzymes such as lignin peroxidase, manganese peroxidase, laccases and various peroxidases, which mineralize lignin efficiently. We review here applications of ligninolytic enzymes for the delignification of lignocellulosic materials, the removal of recalcitrant organic pollutants, wastewater treatment, decolorization of dyes, soil treatment, conversion of high molecular weight coal fractions to low molecular weight coal fractions, which could be used as a feed stock for the production of commodity chemicals, biopulping and biobleaching in paper industries and enzymatic polymerization in polymer industries.

9PL[M~v(hidpa)~]-[hidpas-= (oxyimino)dipropionate(3-)] has been synthesised and shown to possess the novel, octacoordinated structure identified for Amavadin, the form in which vanadium(iv) is bound in Amanita muscaria mushrooms; [Mov(hidpaj2]-is capable of both a one-electron reduction and a one-electron oxidation.

No abstract

No abstract